Xuben Hou
Impact in
- Geriatrics and Gerontology top 5%
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Protein Tyrosine Phosphatases
- Inflammasome and immune disorders
Papers in
-
- Histone Deacetylase Inhibitors Research 24
- Protein Degradation and Inhibitors 18
- Protein Tyrosine Phosphatases 16
- Cell death mechanisms and regulation 11
- Oncology 27
- Peptidase Inhibition and Analysis 11
- Co-authors
- Hao Fang (62 shared papers)Xinying Yang (25 shared papers)Yingkai Zhang (10 shared papers)Jintong Du (15 shared papers)Liang Tao (8 shared papers)Cai Zhang (1 shared paper)Zhigang Tian (1 shared paper)Xin Yu (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry (12 papers)European Journal of Medicinal Chemistry (9 papers)Journal of Chemical Information and Modeling (7 papers)Journal of Medicinal Chemistry (7 papers)Current Medicinal Chemistry (5 papers)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Xuben Hou
83 papers receiving 1.9k citations
Xuben Hou's Hit Papers
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 62
- Molecular Biology 1.3k
- Organic Chemistry 416
- Toxicology 45
- Oncology 318
Countries citing papers authored by Xuben Hou
This map shows the geographic impact of Xuben Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuben Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuben Hou more than expected).
Fields of papers citing papers by Xuben Hou
This network shows the impact of papers produced by Xuben Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuben Hou. The network helps show where Xuben Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Xuben Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 303 | |
| 2 | Targeting histone deacetylases for cancer therapy: Trends and challenges Hit paper breakdown → | 2023 | 129 |
| 3 | 2012 | 114 | |
| 4 | 2020 | 95 | |
| 5 | 2019 | 86 | |
| 6 | 2016 | 82 | |
| 7 | 2021 | 59 | |
| 8 | 2013 | 58 | |
| 9 | 2020 | 48 | |
| 10 | 2012 | 46 | |
| 11 | 2015 | 39 | |
| 12 | 2021 | 38 | |
| 13 | 2015 | 37 | |
| 14 | 2017 | 37 | |
| 15 | 2014 | 35 | |
| 16 | 2015 | 28 | |
| 17 | 2014 | 28 | |
| 18 | 2022 | 28 | |
| 19 | 2015 | 27 | |
| 20 | 2021 | 25 |
About Xuben Hou
Xuben Hou is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Immunology and Computational Theory and Mathematics, having authored 88 papers that have together received 1.9k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (24 papers), Protein Degradation and Inhibitors (18 papers), Protein Tyrosine Phosphatases (16 papers), Galectins and Cancer Biology (11 papers), Peptidase Inhibition and Analysis (11 papers), Cell death mechanisms and regulation (11 papers), Click Chemistry and Applications (9 papers) and Computational Drug Discovery Methods (7 papers). The work is most often cited by research in Geriatrics and Gerontology (62 citations), Molecular Biology (1.3k citations), Organic Chemistry (416 citations), Toxicology (45 citations) and Oncology (318 citations). Xuben Hou has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Hao Fang, Xinying Yang, Yingkai Zhang, Jintong Du, Liang Tao, Cai Zhang, Zhigang Tian, Xin Yu, Peixiang Lan and Nan Lü. Their work appears in journals such as Bioorganic & Medicinal Chemistry, European Journal of Medicinal Chemistry, Journal of Chemical Information and Modeling, Journal of Medicinal Chemistry and Current Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.